After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Vertex Pharmaceuticals, Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Vertex Pharmaceuticals, Inc is $121.13B. A total of 2.19 million shares were traded on the day, compared to an average of 1.63M shares.
In the most recent transaction, ALTSHULER DAVID sold 15 shares of VRTX for 478.56 per share on Nov 15 ’24. After the transaction, the EVP, Chief Scientific Officer now owns 25,813 company shares. In a previous transaction on Nov 15 ’24, ALTSHULER DAVID bought 15 shares at 478.56 per share.
Among the insiders who sold shares, WAGNER CHARLES F JR disposed of 3,000 shares on Nov 11 ’24 at a per-share price of $518.27. This resulted in the EVP & Chief Financial Officer holding 44,137 shares of VRTX after the transaction. In another insider transaction, Kewalramani Reshma sold 15,198 shares at $515.00 per share on Nov 08 ’24. Company shares held by the CEO & President now total 75,772.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, VRTX has a high of $519.88 and a low of $377.85.
As of this writing, VRTX has an earnings estimate of $4.02 per share for the current quarter. EPS was calculated based on a consensus of 25.0 estimates, with a high estimate of $4.85 per share and a lower estimate of $3.41.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. VRTX’s latest balance sheet shows that the firm has $7.52B in Cash & Short Term Investments as of fiscal 2021. There were $967.40M in debt and $2.14B in liabilities at the time. Its Book Value Per Share was $60.65, while its Total Shareholder’s Equity was $10.10B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VRTX is Buy with a score of 4.06.
